P16.04 USE OF 18F-FLUOROMETHYLCHOLINE PET IN EARLY TREATMENT RESPONSE ASSESSMENT IN GLIOBLASTOMA PATIENTS

Por Bolcaen, J., Acou, M., Boterberg, T., Deblaere, K., De Vos, F., Hallaert, G., Kalala, J., Van den Broecke, C.
Publicado em 2014

P07.22 Kinetic modeling and graphical analysis of 18F-fluoromethylcholine (FCho), 18F-fluoroethyltyrosine (FET) and 18F-fluorodeoxyglucose (FDG) PET for the discrimination between...

Por Bolcaen, J., Lybaert, K., Moerman, L., Descamps, B., Deblaere, K., Boterberg, T., Kalala, J., De Vos, F., Vanhove, C., Goethals, I.
Publicado no Neuro Oncol (2016)

P04.26 In vitro and in vivo evaluation of the LAT1 PET tracer 2-[(18)F]FELP in comparison to [(18)F]FET and [(18)F]FDG

Por Verhoeven, J., Bolcaen, J., Kersemans, K., De Meulenaere, V., Deblaere, K., Kalala, J., Van den Broecke, C., Vanhove, C., Goethals, I., De Vos, F.
Publicado no Neuro Oncol (2017)